Inhibition of TNF-α signaling is a successful treatment strategy for many inflammatory and autoimmune diseases, such as rheumatoid arthritis (RA), ankylosing spondylitis, and inflammatory bowel diseases. This evidence concerns the gene TNF and rheumatoid arthritis.